Japanese pharmaceutical company Daiichi Sankyo has formed a captive on Bermuda, according to the latest filings release by the Bermuda Monetary Authority (BMA).
The second-largest pharmaceutical company in Japan formed a Class 1 insurer on June 26 this year.
The revelation was part of a wider report showing that 32 re/insurer registrations and five intermediaries were registered on the island over the first half of 2019. In 2018, 75 entities were registered in total and in 2017 58 were registered.
Daiichi Sankyo, BMA, Captive, Pharmaceutical, Reinsurance, Insurance, Japan, Bermuda